p53 and RB: Simple Interesting Correlates or Tumor Markers of Critical Predictive Nature?
- 15 March 2004
- journal article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (6) , 975-977
- https://doi.org/10.1200/jco.2004.12.994
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Prevalence of adenomas and hyperplastic polyps in carriers of HNPCC (LYNCH Syndrome)Journal of Clinical Oncology, 2004
- RARbeta P2 promoter methylation: Potential biomarker for use with breast Random Periareolar Fine Needle Aspiration in breast cancer risk assessmentJournal of Clinical Oncology, 2004
- Issues and barriers to development of clinically useful tumor markers: A development pathway proposalSeminars in Oncology, 2002
- The INK4a/ARF tumor suppressor: one gene—two products—two pathwaysTrends in Biochemical Sciences, 1998
- Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor MarkersJNCI Journal of the National Cancer Institute, 1996
- p53 anderbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancerVirchows Archiv, 1993
- Altered Expression of the Retinoblastoma Gene Product: Prognostic Indicator in Bladder CancerJNCI Journal of the National Cancer Institute, 1992
- The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells.Proceedings of the National Academy of Sciences, 1991
- Identification of p53 Gene Mutations in Bladder Cancers and Urine SamplesScience, 1991